Literature DB >> 18991285

Arthritogenic dsRNA is present in synovial fluid from rheumatoid arthritis patients with an erosive disease course.

Maria Bokarewa1, Andrej Tarkowski, Magnus Lind, Leif Dahlberg, Mattias Magnusson.   

Abstract

Viruses may be part of the pathogenesis of rheumatoid arthritis (RA). Double stranded RNA (dsRNA) is a prototypic viral conformation of nucleic acid that is highly arthritogenic in mice. Therefore, we developed an ELISA to detect dsRNA in sera and synovial fluids (SF) in RA patients and in osteoarthritic controls. The developed ELISA recognizes picogram levels of viral or synthetic dsRNA but shows no reactivity against DNA, synthetic ssRNA, or total RNA prepared from mammalian cells. Before analysis by ELISA, each sample was subjected to RNA precipitation. The RA patients had significantly higher levels of dsRNA than the osteoarthritis patients in SF and in sera. In 7 of 17 RA patients, EBV was present in SF and in all but one of these this was accompanied by the presence of dsRNA. No parvovirus, cytomegalovirus, or polyomavirus was detected. The anti-viral cytokine IFN-alpha was detected in SF in 10 of 21 RA patients, but in none of the osteoarthritis patients. Notably, RA patients with erosive disease course had significantly higher levels of dsRNA in SF than non-erosive patients, but no correlation between dsRNA levels and the presence of RF or levels of C-reactive protein, IL-6, or IFN-alpha was observed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991285     DOI: 10.1002/eji.200838362

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.

Authors:  Pierre Duffau; Hanni Menn-Josephy; Carla M Cuda; Salina Dominguez; Tamar R Aprahamian; Amanda A Watkins; Kei Yasuda; Paul Monach; Robert Lafyatis; Lisa M Rice; G Kenneth Haines; Ellen M Gravallese; Rebecca Baum; Christophe Richez; Harris Perlman; Ramon G Bonegio; Ian R Rifkin
Journal:  Arthritis Rheumatol       Date:  2015-12       Impact factor: 10.995

Review 2.  Persistent RNA virus infections: do PAMPS drive chronic disease?

Authors:  Mary K McCarthy; Thomas E Morrison
Journal:  Curr Opin Virol       Date:  2017-02-17       Impact factor: 7.090

3.  Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.

Authors:  Mattias Magnusson; Mikael Brisslert; Kiandoht Zendjanchi; Magnus Lindh; Maria I Bokarewa
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

4.  Engagement of toll-like receptor 3 induces vascular endothelial growth factor and interleukin-8 in human rheumatoid synovial fibroblasts.

Authors:  Su-Jin Moon; Mi-Kyung Park; Hye-Jwa Oh; Seon-Yeong Lee; Seung-Ki Kwok; Mi-La Cho; Ji Hyeon Ju; Kyung-Su Park; Ho-Youn Kim; Sung-Hwan Park
Journal:  Korean J Intern Med       Date:  2010-11-27       Impact factor: 2.884

5.  Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation.

Authors:  Huiyi Liang; Bo Peng; Cong Dong; Lixin Liu; Jiaji Mao; Song Wei; Xinlu Wang; Hanshi Xu; Jun Shen; Hai-Quan Mao; Xiaohu Gao; Kam W Leong; Yongming Chen
Journal:  Nat Commun       Date:  2018-10-16       Impact factor: 14.919

Review 6.  Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology.

Authors:  Sarah Unterberger; Kevin A Davies; Srinivasa Bhargav Rambhatla; Sandra Sacre
Journal:  Immunotargets Ther       Date:  2021-07-28

7.  Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment.

Authors:  Lisa Gm van Baarsen; Carla A Wijbrandts; François Rustenburg; Tineke Cantaert; Tineke Ctm van der Pouw Kraan; Dominique L Baeten; Ben Ac Dijkmans; Paul P Tak; Cornelis L Verweij
Journal:  Arthritis Res Ther       Date:  2010-01-22       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.